hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06280456, orgStudyIdInfo id: 2023-09-017A, briefTitle: Tranexamic Acid Injection With Different Drainage Clamping Time After Anterior Cruciate Ligament Reconstruction, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-05, primaryCompletionDateStruct date: 2023-01-05, completionDateStruct date: 2023-02-05, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Taipei Veterans General Hospital, Taiwan, class: OTHER_GOV, descriptionModule briefSummary: Post-anterior cruciate ligament reconstruction (ACLR) hemarthrosis may result in increased pain thus delaying postoperative rehabilitation, which may eventually lead to arthrofibrosis and a functional deficit. Many antifibrinolytic agents, including tranexamic acid (TXA), have been used in orthopedic surgeries to reduce postoperative bleeding. Moreover, TXA was proved effective to reduced the events of hemarthrosis and increased the post-operative functional outcomes of the patients in several studies. The purpose of this study is to evaluate the efficacy of intra-articular injection of TXA with different drainage clamping time in patients receiving arthroscopic ACLRs. Patients were randomized into four groups. An intra-articular suction drain was placed recorded 24 h postoperatively. Group 1 patients(TXA 4hr group) received the index procedures with a 10 mL intra-articular injection of TXA and following drainage clamped 4 hours. Group 2 patients(TXA 8hr group) received the index procedures with a 10 mL intra-articular injection of TXA and following drainage clamped 8 hours. Clinical evaluations using an IKDC functional score and a Visual Analogue Scale (VAS) pain score were performed during admission, at postoperative day 3 and week 4., conditionsModule conditions: Anterior Cruciate Ligament Reconstruction, conditions: Tranexamic Acid, conditions: Hemarthrosis, Knee, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 150, type: ACTUAL, armsInterventionsModule interventions name: Tranexamic Acid Powder, outcomesModule primaryOutcomes measure: The volume of drainage, secondaryOutcomes measure: Visual analog scale (VAS), secondaryOutcomes measure: International Knee Documentation Committee (IKDC) functional score, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Taipei Veterans General Hospital, city: Taipei, country: Taiwan, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False
protocolSection identificationModule nctId: NCT06280443, orgStudyIdInfo id: CE22407B, briefTitle: Sarcopenia in Chronic Lung Diseases, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-11-25, primaryCompletionDateStruct date: 2024-10-13, completionDateStruct date: 2032-09-30, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-04-04, sponsorCollaboratorsModule leadSponsor name: Taichung Veterans General Hospital, class: OTHER, descriptionModule briefSummary: Inclusion criteria A)Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.B) Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources, conditionsModule conditions: Sarcopenia, conditions: COPD, conditions: Asthma, conditions: ILD, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 300, type: ESTIMATED, outcomesModule primaryOutcomes measure: sarcopenia rate, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Taichung Veterans General Hospital, status: RECRUITING, city: Taichung, zip: 40705, country: Taiwan, contacts name: Pin-Kuei Fu, MD, PhD, role: CONTACT, phone: 886-4-23592525, phoneExt: 3213, email: yetquen@gmail.com, geoPoint lat: 24.1469, lon: 120.6839, hasResults: False
protocolSection identificationModule nctId: NCT06280430, orgStudyIdInfo id: Vascular affection in behcet, briefTitle: Vascular Affection in Behcet Disease, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2025-03-01, completionDateStruct date: 2025-04-01, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity, conditionsModule conditions: Behcet Disease and Vascular Involvement, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: RETROSPECTIVE, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: To measure the level of serum elafin in behcet patients and compare it with control group, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 45 Years, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06280417, orgStudyIdInfo id: Unreamed IMN In IIIa tibia, briefTitle: Unreamed Intramedullary Tibial Nailing in Treatment of Open IIIa Diaphyseal Tibial Fractures in Adults, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2025-08-01, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: To study the incidence of non union of Unreamed intramedullary nailing in type IIIa Open diaphyseal fractures of the tibia as a primary outcome and the incidence of complications and clinical and functional outcome as a secondary outcome ., conditionsModule conditions: Tibia Fracture, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: Unreamed intramedullary tibial nail, outcomesModule primaryOutcomes measure: Incidence of non union, secondaryOutcomes measure: Incidince of fracture related infection, secondaryOutcomes measure: The rate of reoperation for delayed union or non-union, infection and fasciotomy, secondaryOutcomes measure: functional evaluation, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06280404, orgStudyIdInfo id: Body first in lap chole, briefTitle: Body First Approach in Lap Cholecystectomy in Cases With Obscure Calot's Triangle, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2025-03-15, completionDateStruct date: 2025-08-08, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: The aim of this study is to evaluate the body first approach on the rate of conversion to open technique \& VBI in patients with obscure calot's triangle., conditionsModule conditions: Cholecystitis, Chronic, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Lap cholecystectomy, outcomesModule primaryOutcomes measure: Safe laparoscopic cholecystectomy., secondaryOutcomes measure: Evaluation of the body first approach technique, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06280378, orgStudyIdInfo id: CP-KL003-003/01, briefTitle: A Phase I/II Clinical Study of the KL003 Cell Injection in β-Thalassemia Major Participants, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02, primaryCompletionDateStruct date: 2025-05, completionDateStruct date: 2027-05, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Kanglin Biotechnology (Hangzhou) Co., Ltd., class: INDUSTRY, descriptionModule briefSummary: This is a non-randomized, open label, single-dose study in up to 41 participants with β-thalassemia major. The goal of this clinical trial is to evaluate the safety and efficacy of KL003 cell injection in subjects with β-thalassemia major., conditionsModule conditions: Transfusion-dependent Beta-Thalassemia, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 41, type: ESTIMATED, armsInterventionsModule interventions name: KL003 Cell Injection Drug Product, outcomesModule primaryOutcomes measure: KL003 engraftment, primaryOutcomes measure: Engraftment time of neutrophil and platelet, primaryOutcomes measure: Overall Survival, primaryOutcomes measure: The number, frequency and severity of adverse events (AE) within 1 year after infusion of KL003 drug products, primaryOutcomes measure: Clonal dominance or secondary tumors caused by lentiviral vector insertional-mutation, primaryOutcomes measure: Numbers of Participants With Vector-Derived Replication-Competent Lentivirus (RCL), secondaryOutcomes measure: The proportion of participants achieved Transfusion Independence (TI)for at least 6 months, secondaryOutcomes measure: The proportion of participants achieved TI 12, secondaryOutcomes measure: The start time of Transfusion Independence (TI) after KL003 infusion, secondaryOutcomes measure: Total Hb and the vector-derived HbA^T87Q, eligibilityModule sex: ALL, minimumAge: 3 Years, maximumAge: 35 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Ruijin Hospital, Shanghai Jiaotong University School of Medicine, city: Shanghai, state: Shanghai, country: China, contacts name: Wei Tang, PhD, role: CONTACT, phone: +86 13472889588, contacts name: Saijuan Chen, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 31.22222, lon: 121.45806, locations facility: Institute of Hematology & Blood Diseases Hospital, city: Tianjin, state: Tianjin, country: China, contacts name: Zhen Gao, Master, role: CONTACT, phone: +86 15522360862, email: Gaozhen@ihcams.ac.cn, contacts name: Jun Shi, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.14222, lon: 117.17667, hasResults: False
protocolSection identificationModule nctId: NCT06280365, orgStudyIdInfo id: 012, briefTitle: MWM Technique in Patients With Knee OA, statusModule overallStatus: COMPLETED, startDateStruct date: 2024-02-19, primaryCompletionDateStruct date: 2024-03-15, completionDateStruct date: 2024-03-15, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-04-03, sponsorCollaboratorsModule leadSponsor name: Okan University, class: OTHER, descriptionModule briefSummary: The aim of this study is to investigate the effect of the MWM technique on pain, normal joint movement, proprioception and quality of life in patients with knee osteoarthritis (OA)., conditionsModule conditions: Mobilization, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ACTUAL, armsInterventionsModule interventions name: Mulligan Mobilization with Movement Technique, outcomesModule primaryOutcomes measure: Visual Analog Scale (VAS), primaryOutcomes measure: Short form-36 (SF-36), primaryOutcomes measure: Western Ontario and Mcmaster Universities Osteoarthritis Index (WOMAC), primaryOutcomes measure: Evaluation of proprioception, primaryOutcomes measure: The range of motion, eligibilityModule sex: ALL, minimumAge: 25 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Emine Atıcı, city: Tuzla, state: İstanbul, country: Turkey, hasResults: False
protocolSection identificationModule nctId: NCT06280352, orgStudyIdInfo id: AUVA_Knieathlon_2024, briefTitle: Robotic Assisted vs Custom Made Total Knee Arthroplasty, acronym: Knieathlon, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Austrian Workers Compensation Board Styria, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to compare Robotic Assisted, functionally aligned vs Custom Made Total Knee Arthroplasty in patients with knee osteoarthritis. The main questions it aims to answer are:* Which implant/philosophy yields better clinical outcomes?* Which implant/philosophy yields better satisfaction?* Which system is more OR efficient? Participants will be followed for 2 years postoperatively., conditionsModule conditions: Knee Osteoarthritis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Custom made Total Knee Arthroplasty, interventions name: Functionally aligned robotically assisted total knee arthroplasty, outcomesModule primaryOutcomes measure: Clinical Outcome using the Forgotten Joint Score, secondaryOutcomes measure: Clinical outcomes using the Kujala anterior knee pain Score, secondaryOutcomes measure: Patient satisfaction, secondaryOutcomes measure: Visual analog pain (VAS) scale, secondaryOutcomes measure: Surgical and total theatre time, secondaryOutcomes measure: Opioid use, secondaryOutcomes measure: Number of physiotherapy sessions, secondaryOutcomes measure: Range of motion measurements (in degrees), secondaryOutcomes measure: Radiographic data including radiolucent lines, secondaryOutcomes measure: Revision rate, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 90 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: AUVA UKH Steiermark Standort Graz, status: RECRUITING, city: Graz, state: Styria, zip: 8020, country: Austria, contacts name: Antonio Klasan, MD, PHD, EMBA, role: CONTACT, geoPoint lat: 47.06667, lon: 15.45, locations facility: AUVA UKH Steiermark Standort Kalwang, status: RECRUITING, city: Kalwang, state: Styria, zip: 8775, country: Austria, contacts name: Antonio Klasan, MD, PhD, EMBA, role: CONTACT, geoPoint lat: 47.42172, lon: 14.75221, documentSection largeDocumentModule largeDocs typeAbbrev: Prot_SAP, hasProtocol: True, hasSap: True, hasIcf: False, label: Study Protocol and Statistical Analysis Plan, date: 2023-11-27, uploadDate: 2024-02-05T09:59, filename: Prot_SAP_000.pdf, size: 156436, hasResults: False
protocolSection identificationModule nctId: NCT06280339, orgStudyIdInfo id: IRB23-0190, briefTitle: Food Cravings Strategies During Dietary Weight Loss, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-29, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-08-01, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: University of Illinois at Urbana-Champaign, class: OTHER, descriptionModule briefSummary: The purpose is to optimize the EMPOWER program by integrating strategies to reduce food cravings, a critical yet often overlooked factor for long-term success in weight management.The objective of this study is to determine the efficacy of craving coping strategies on weight loss outcomes by conducting a randomized controlled trial. Participants will be randomized to receive one of the two strategies to manage food cravings., conditionsModule conditions: Obesity, conditions: Food Cravings, conditions: Weight Loss, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants will be enrolled in dietary weight loss program. Before the first meeting they will be randomized to one of the two study groups that focus on teaching participants different strategies to cope with food cravings (Inclusion vs. Avoidance).. To ensure balanced representation and meaningful study results, the randomization process will consider specific characteristics, including BMI category, sex, and age. This stratified randomization method helps us compare the effects of the intervention between different groups of participants., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Test two food cravings strategies during dietary weight loss, interventions name: Dietary weight loss program +Food cravings strategies, outcomesModule primaryOutcomes measure: Body weight, primaryOutcomes measure: Food Craving Strategies Compliance, primaryOutcomes measure: Food Cravings, primaryOutcomes measure: Food Cravings, secondaryOutcomes measure: Dietary intake, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Bevier HAll UIUC, status: RECRUITING, city: Urbana, state: Illinois, zip: 61801, country: United States, contacts name: Nouf Alfouzan, role: CONTACT, phone: 217-898-5480, email: noufa2@illinois.edu, geoPoint lat: 40.11059, lon: -88.20727, locations facility: Bevier HAll UIUC, status: RECRUITING, city: Urbana, state: Illinois, zip: 61801, country: United States, contacts name: Nouf Alfouzan, role: CONTACT, phone: 217-898-5480, email: noufa2@illinois.edu, contacts name: Manabu Nakamura, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.11059, lon: -88.20727, hasResults: False
protocolSection identificationModule nctId: NCT06280326, orgStudyIdInfo id: Orogastric Tube Removal, briefTitle: Effect of Different Materials Used in Orogastric Tube Removal on Skin Condition in Premature Babies, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-02-05, primaryCompletionDateStruct date: 2024-06-05, completionDateStruct date: 2024-08-05, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Ondokuz Mayıs University, class: OTHER, descriptionModule briefSummary: While medical adhesives provide fixation of devices and catheters in neonatal intensive care, problems such as disruption of skin integrity are frequently encountered when removed. The study aims to compare the effectiveness of sunflower oil and silicone-based remover spray used during the removal of medical adhesives used in oragastric catheter fixation in preterm babies in the Neonatal Intensive Care Unit in preventing skin damage., conditionsModule conditions: Neonatal Skin Conditions, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized controlled experimental trial, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 86, type: ACTUAL, armsInterventionsModule interventions name: Sunflower oil, interventions name: Slicone based spray, outcomesModule primaryOutcomes measure: Neonatal Skin Condition Score, eligibilityModule sex: ALL, minimumAge: 32 Weeks, maximumAge: 36 Weeks, stdAges: CHILD, contactsLocationsModule locations facility: Hatice Uzşen, city: Samsun, state: Atakum, zip: 55100, country: Turkey, geoPoint lat: 41.27976, lon: 36.3361, hasResults: False
protocolSection identificationModule nctId: NCT06280300, orgStudyIdInfo id: UVMMC2203, briefTitle: Multi-disciplinary Care for Brain Metastases, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-16, primaryCompletionDateStruct date: 2024-11-01, completionDateStruct date: 2025-11-01, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: University of Vermont Medical Center, class: OTHER, descriptionModule briefSummary: This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases., conditionsModule conditions: Brain Metastases, Adult, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: cohort study, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: health services intervention, outcomesModule primaryOutcomes measure: Patient reported outcomes, secondaryOutcomes measure: Feasibility, secondaryOutcomes measure: Patient understanding of prognosis, secondaryOutcomes measure: survival, otherOutcomes measure: Exploratory survival outcome, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Vermont Medical Center, status: RECRUITING, city: Burlington, state: Vermont, zip: 05401, country: United States, geoPoint lat: 44.47588, lon: -73.21207, hasResults: False
protocolSection identificationModule nctId: NCT06280287, orgStudyIdInfo id: FAPI-PLAQUE, briefTitle: PET Imaging of Fibroblast Activation in Atherosclerosis, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-08-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-02-28, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Peking Union Medical College Hospital, class: OTHER, descriptionModule briefSummary: Fibroblast activation protein (FAP) is a fibroblast-specific marker expressed in atherosclerosis, associated with endothelial-to-mesenchymal transition and a rupture-prone plaque phenotype. This study aims to evaluate in-vivo fibroblast activation in carotid and coronary atherosclerotic diseases with FAPI PET and its correlation with histological vulnerability and clinical outcome., conditionsModule conditions: Atherosclerosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 150, type: ESTIMATED, armsInterventionsModule interventions name: FAPI PET, outcomesModule primaryOutcomes measure: SUVmax of atherosclerotic plaque in carotid or coronary arteries, primaryOutcomes measure: TBR of atherosclerotic plaque in carotid or coronary arteries, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 90 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Peking Union Medical College Hospital, status: RECRUITING, city: Beijing, state: Beijing, zip: 100730, country: China, contacts name: Li Huo, role: CONTACT, phone: 86-13910801986, email: huoli@pumch.cn, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False